The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer

Clinical Cancer Research

Volumn 10, Issue 16, 2004, Pages 5572-5579

  Takeuchi, Taku ^a   Hisanaga, Michiyoshi ^a   Nagao, Mitsuo ^a   Ikeda, Naoya ^a   Fujii, Hisao ^a   Koyama, Fumikazu ^a   Mukogawa, Tomohide ^a   Matsumoto, Hiroshi ^a   Kondo, Shunya ^b   Takahashi, Chiaki ^b   Noda, Makoto ^b   Nakajima, Yoshiyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; REVERSION INDUCING CYSTEINE RICH PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN TARGETING; REGULATORY MECHANISM; SCORING SYSTEM; ZYMOGRAPHY;

AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 4143058084     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0656     Document Type: Article

References (20)

1. Noda M, Kitayama H, Matsuzaki T, et al. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl Acad Sci USA 1989;86:162-6.
2. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M. A ras-related gene with transformation suppressor activity. Cell 1989;56: 77-84.
3. Takahashi C, Akiyama N, Matsuzaki T, et al. Characterization of human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene. Oncogene 1996;12: 2137-46.
4. Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 1998;95: 13221-6.
5. Sasahara RM, Takahashi C, Noda M. Involvement of Sp1 site in ras mediated downregulation of RECK metastasis suppressor gene. Biochem Biophys Res Commun 1999;264:668-75.
6. Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001;107:789-800.
7. Sunami E, Tsuno N, Osada T, et al. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 2000;5: 108-14.
8. Zeng Z-S, Snu W-P, Cohen AM, Guillem JG. Matrix metalloproteinase-7 expression in colorectal cancer liver metastasis: evidence for involvement of MMP-7 activation in human cancer metastasis. Clin Cancer Res 2002;8:144-8.
9. Portera CA Jr, Berman RS, Ellis LM. Molecular determinants of colon cancer metastasis. Surg Oncol 1998;7:183-95.
10. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44.
11. Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells. J Biol Chem 1992;267:21712-9.
12. Kawahara E, Okada Y, Nakanishi I, et al. The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res 1993;84:409-18.
13. Bossi P, Viale G, Lee AKC, et al. Angiogenesis in colorectal tumors: microvessel quantification in adenomas and carcinomas with clinicopathological correlations. Cancer Res 1995;55:5049-53.
14. Haerron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z. Secretion of metalloproteinase by stimulated capillary endothelial cells. J Biol Chem 1986;261:2814-8.
15. Bos JL. ras oncogenes in human cancer. Cancer Res 1989;49: 4682-9.
16. Fagan JB, Sobel ME, Yamada KM, de Crombrugghe B, Pastan I. Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA. J Biol Chem 1981;256:520-5.
17. Howard BH, Adams SL, Sobel ME, Pastan I, de Crombrugghe B. Decreased levels of collagen mRNA in Rous sarcoma virus-transformed chick embryo fibroblasts. J Biol Chem 1978;253:5869-74.
18. Masui T, Doi R, Koshiba T, et al. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res 2003;9:1779-84.
19. Span PN, Sweep CG, Manders P, et al. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer (Phila) 2003;97:2710-5.
20. Furumoto K, Arii S, Mori A, et al. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Hepatology 2001;33: 189-95.